semaglutide analogues Schematic representation of different GLP-1 previously Altamiro Bottino | Glucagon-like peptide-1

More common side effects include nausea/vomiting and pancreatitis

There are also patients who decide semaglutide is simply not worth the side effects, even if it is effective

JMs background metformin was continued As stressed in the ADA Standards of Care, metformin remains the recommended first-line pharmacologic therapy in patients with T2D and should be continued with the addition of other glucose-lowering therapies in those who can tolerate and do not have a contraindication to metformin therapy

all treatment plans come with ongoing clinical support at no extra fee

As GLP-1 adoption grows, food companies will face new challenges particularly declining demand for processed foods but also new opportunities, like increased demand for fruits and vegetables